Compound_ID |
Target |
Gene_Name |
Gene_ID |
Cancer |
Cell_lines |
IC50 Value |
EC50 Value |
ED50 Value |
GI50 Value |
Remarks |
References |
MMP-AC0226 |
BCL2-associated X protein |
581 |
sarcoma |
S180 |
|
- |
- |
- |
- |
After the seven-day treatments by the route of i.v., wogonin (20, 40mg/kg) had significant inhibitory effect on the growth of inoculated S180 in mice. The inhibitory rates was 34.24%.After mice with S180 were treated with wogonin (20,40mg/kg) seven times intravenously,wogonin could increase the levels of bax mRNA and bax protein in a concentration-dependent manner. |
16755005 |
MMP-AC0226 |
BCL2 |
B-cell CLL/lymphoma 2 |
596 |
sarcoma |
S180 |
- |
- |
- |
- |
After the seven-day treatments by the route of i.v., wogonin (20, 40mg/kg) had significant inhibitory effect on the growth of inoculated S180 in mice. The inhibitory rates was 34.24%. After mice with S180 were treated with wogonin (20,40mg/kg) seven times intravenously,wogonin could lower the level of bcl-2 mRNA and bcl-2 protein. |
16755005 |
MMP-AC0226 |
CDK7 |
cyclin-dependent kinase 7 |
1022 |
T-cell Leukemia |
CEM |
12.3 µM |
- |
- |
- |
CDK7 is a component of the transcription factor TFIIH, which phosphorylates Ser5 residues in the heptad repeats of the carboxy-terminal domain (CTD) of RNA polymerase II (RNAPII) to facilitate transcription initiation. |
21776020 |
MMP-AC0226 |
CDK9 |
cyclin-dependent kinase 9 |
1025 |
T-cell Leukemia |
CEM |
0.19 µM |
- |
- |
- |
Wogonin preferentially inhibits CDK9 in malignant compared with normal lymphocytes. |
21776020 |
MMP-AC0226 |
MCL1 |
myeloid cell leukemia sequence 1 (BCL2-related) |
4170 |
Adult T-cell leukemia (ATL) |
HTLV-1-SP |
- |
- |
- |
- |
Wogonin downregulates Mcl-1 protein expression in malignant cells. |
21776020 |
MMP-AC0226 |
MCL1 |
myeloid cell leukemia sequence 1 (BCL2-related) |
4170 |
Colon cancer |
HCT-116 |
- |
- |
- |
- |
Wogonin downregulates Mcl-1 protein expression in malignant cells. |
21776020 |
MMP-AC0226 |
MCL1 |
myeloid cell leukemia sequence 1 (BCL2-related) |
4170 |
T-cell Leukemia |
CEM |
- |
- |
- |
- |
Wogonin downregulates Mcl-1 protein expression in malignant cells. |
21776020 |
MMP-AC0226 |
TP53 |
tumor protein p53 |
7157 |
sarcoma |
S180 |
- |
- |
- |
- |
After the seven-day treatments by the route of i.v., wogonin (20, 40mg/kg) had significant inhibitory effect on the growth of inoculated S180 in mice. The inhibitory rates was 34.24%. After mice with S180 were treated with wogonin (20,40mg/kg) seven times intravenously,wogonin could increase the levels of p53 mRNA dramatically in a concentration-dependent manner. |
16755005 |